BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...
Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...
BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Labcorp continues string of ...
ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ -- BioReference ® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a ...
ELMWOOD PARK, N.J., April 29, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an ...
ELMWOOD PARK, N.J., Feb. 9, 2023 /PRNewswire/ -- BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first ...
Transaction to extend Labcorp's (LH) leadership in oncology and expand access to the company's high-quality clinical laboratory services Through this transaction, Labcorp will acquire BioReference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results